Helmy Eltoukhy - 09 Sep 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
09 Sep 2025
Net transactions value
-$17,835,995
Form type
4
Filing time
11 Sep 2025, 19:14:46 UTC
Previous filing
02 Jul 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Eltoukhy Helmy Co-Chief Executive Officer, Director 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy 11 Sep 2025 0001752968

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Sale $17,519,720 -294,723 -12% $59.44 2,128,776 09 Sep 2025 Direct F1
transaction GH Common Stock Sale $316,275 -5,277 -0.25% $59.93 2,123,499 09 Sep 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.79 to $59.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.79 to $60.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.